These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 28010860)

  • 1. Invited commentary.
    Ozaki CK
    J Vasc Surg; 2017 Jan; 65(1):206. PubMed ID: 28010860
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited commentary.
    Guzman RJ
    J Vasc Surg; 2017 Jan; 65(1):217-218. PubMed ID: 28010861
    [No Abstract]   [Full Text] [Related]  

  • 3. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
    Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ET block and the neointima: not the B, that is the answer.
    Coleman HA; Parkington HC
    Cardiovasc Res; 2012 Jul; 95(1):1-2. PubMed ID: 22637749
    [No Abstract]   [Full Text] [Related]  

  • 5. Invited commentary.
    Landry GJ
    J Vasc Surg; 2019 Sep; 70(3):785. PubMed ID: 31445648
    [No Abstract]   [Full Text] [Related]  

  • 6. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
    Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury.
    Fuseya T; Furuhashi M; Matsumoto M; Watanabe Y; Hoshina K; Mita T; Ishimura S; Tanaka M; Miura T
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New endoplasmic reticulum stress regulator, Gipie, regulates the survival of vascular smooth muscle cells and the neointima formation after vascular injury.
    Noda T; Maeda K; Hayano S; Asai N; Enomoto A; Takahashi M; Murohara T
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1246-53. PubMed ID: 25792451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.
    Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
    Eur J Pharmacol; 2018 Feb; 820():222-228. PubMed ID: 29269019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Differences on Neointima Formation in Immunodeficient and Humanized Mice after Carotid or Femoral Arterial Injury.
    Moser J; van Ark J; van Dijk MC; Greiner DL; Shultz LD; van Goor H; Hillebrands JL
    Sci Rep; 2016 Oct; 6():35387. PubMed ID: 27759053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of adenosine kinase inhibition in vascular disease.
    Tual-Chalot S; Stellos K
    Cardiovasc Res; 2021 Jan; 117(2):354-356. PubMed ID: 32533148
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
    Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L
    Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
    Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
    Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited commentary.
    Eidt JF
    J Vasc Surg; 2012 May; 55(5):1285-6. PubMed ID: 22542341
    [No Abstract]   [Full Text] [Related]  

  • 17. Ca
    Liu B; Zhang B; Huang S; Yang L; Roos CM; Thompson MA; Prakash YS; Zang J; Miller JD; Guo R
    Can J Cardiol; 2018 Jun; 34(6):791-799. PubMed ID: 29705161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel lipoprotein (a) lowering drug, D-47, decreases neointima thickening after vascular injury.
    Nakaya Y; Fukuda D; Oyamada T; Ogawa K; Harada N; Nakagami H; Morishita R; Sata M; Sakaue H
    J Med Invest; 2017; 64(1.2):64-67. PubMed ID: 28373630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micromanaging restenosis by therapeutic inhibition of miR-92a.
    Squadrito ML; De Palma M
    Cardiovasc Res; 2014 Sep; 103(4):432-4. PubMed ID: 25082845
    [No Abstract]   [Full Text] [Related]  

  • 20. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.